Literature DB >> 18635968

Modulation of integrin-linked kinase nucleo-cytoplasmic shuttling by ILKAP and CRM1.

Kerry-Ann Nakrieko1, Alisa Vespa, David Mason, Timothy S Irvine, Sudhir J A D'Souza, Lina Dagnino.   

Abstract

Integrin-linked kinase (ILK) plays key roles in a variety of cell functions, including cell proliferation, adhesion and migration. Within the cell, ILK localizes to multiple sites, including the cytoplasm, focal adhesion complexes that mediate cell adhesion to extracellular substrates, as well as cell-cell junctions in epidermal keratinocytes. Central to understanding ILK function is the elucidation of the mechanisms that regulate its subcellular localization. We now demonstrate that ILK is imported into the nucleus through sequences in its N-terminus, via active transport mechanisms that involve nuclear pore complexes. In addition, nuclear ILK can be rapidly exported into the cytoplasm through a CRM1-dependent pathway, and its export is enhanced by the type 2C protein phosphatase ILKAP. Nuclear localization of ILK in epidermal keratinocytes is associated with increased DNA synthesis, which is sensitive to inhibition by ILKAP. Our studies demonstrate the importance for keratinocyte proliferation of ILK regulation through changes in its subcellular localization, and establish ILKAP and CRM1 as pivotal modulators of ILK subcellular distribution and activity in these cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18635968     DOI: 10.4161/cc.7.14.6241

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  13 in total

1.  Modulation of type II TGF-β receptor degradation by integrin-linked kinase.

Authors:  Linda Vi; Stellar Boo; Samar Sayedyahossein; Randeep K Singh; Sarah McLean; Gianni M Di Guglielmo; Lina Dagnino
Journal:  J Invest Dermatol       Date:  2014-09-30       Impact factor: 8.551

2.  The Load-Bearing Mechanosome Revisited.

Authors:  Joseph P Bidwell; Fredrick M Pavalko
Journal:  Clin Rev Bone Miner Metab       Date:  2010-11-11

Review 3.  Understanding the molecular basis of cardiomyopathy.

Authors:  Marie-Louise Bang; Julius Bogomolovas; Ju Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-11-19       Impact factor: 5.125

4.  Integrin-linked kinase interactions with ELMO2 modulate cell polarity.

Authors:  Ernest Ho; Tames Irvine; Gregory J A Vilk; Gilles Lajoie; Kodi S Ravichandran; Sudhir J A D'Souza; Lina Dagnino
Journal:  Mol Biol Cell       Date:  2009-05-13       Impact factor: 4.138

Review 5.  Integrin Linked Kinase (ILK) and its Role in Liver Pathobiology.

Authors:  Nicole Martucci; George K Michalopoulos; Wendy M Mars
Journal:  Gene Expr       Date:  2021-01-22

6.  An ELMO2-RhoG-ILK network modulates microtubule dynamics.

Authors:  Bradley C Jackson; Iordanka A Ivanova; Lina Dagnino
Journal:  Mol Biol Cell       Date:  2015-05-20       Impact factor: 4.138

7.  The function of integrin-linked kinase in normal and activated stellate cells: implications for fibrogenesis in wound healing.

Authors:  Mahnoush S Shafiei; Don C Rockey
Journal:  Lab Invest       Date:  2011-11-07       Impact factor: 5.662

8.  Multiple roles of integrin-linked kinase in epidermal development, maturation and pigmentation revealed by molecular profiling.

Authors:  David Judah; Alena Rudkouskaya; Ryan Wilson; David E Carter; Lina Dagnino
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

9.  Reduced expression of enolase-1 correlates with high intracellular glucose levels and increased senescence in cisplatin-resistant ovarian cancer cells.

Authors:  Yasmarie Santana-Rivera; Robert J Rabelo-Fernández; Blanca I Quiñones-Díaz; Nilmary Grafals-Ruíz; Ginette Santiago-Sánchez; Eunice L Lozada-Delgado; Ileabett M Echevarría-Vargas; Juan Apiz; Daniel Soto; Andrea Rosado; Loyda Meléndez; Fatima Valiyeva; Pablo E Vivas-Mejía
Journal:  Am J Transl Res       Date:  2020-04-15       Impact factor: 3.940

10.  XPO1/CRM1-selective inhibitors of nuclear export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa).

Authors:  Giovanni Luca Gravina; Monica Tortoreto; Andrea Mancini; Alessandro Addis; Ernesto Di Cesare; Andrea Lenzi; Yosef Landesman; Dilara McCauley; Michael Kauffman; Sharon Shacham; Nadia Zaffaroni; Claudio Festuccia
Journal:  J Hematol Oncol       Date:  2014-10-05       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.